Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 12:16 pm Unchanged |
2024-09-30 | 13G | Vision Marine Technologies Inc. VMAR |
CVI Investments, Inc. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-10-02 10:53 am Purchase |
2024-09-27 | 13G | Theriva Biologics, Inc. TOVX |
CVI Investments, Inc. | 232,237 9.900% |
232,237 (New Position) |
Filing History |
| 2024-09-18 10:21 am Purchase |
2024-09-13 | 13G | Vision Marine Technologies Inc. VMAR |
CVI Investments, Inc. | 4,611 8.400% |
4,611 (New Position) |
Filing History |
| 2024-09-16 10:22 am Purchase |
2024-09-11 | 13G | BriaCell Therapeutics Corp. BCTX |
CVI Investments, Inc. | 173,913 8.500% |
173,913 (New Position) |
Filing History |
| 2024-08-05 11:53 am Purchase |
2024-07-30 | 13G | Imunon, Inc. IMNN |
CVI Investments, Inc. | 1,220,000 8.500% |
1,220,000 (New Position) |
Filing History |
| 2024-08-01 10:26 am Purchase |
2024-07-24 | 13G | Azitra, Inc. AZTR |
CVI Investments, Inc. | 610,000 8.000% |
610,000 (New Position) |
Filing History |
| 2024-04-09 10:43 am Purchase |
2024-04-05 | 13G | Protara Therapeutics, Inc. TARA |
CVI Investments, Inc. | 600,380 5.300% |
600,380 (New Position) |
Filing History |
| 2024-04-04 10:15 am Purchase |
2024-03-28 | 13G | RENALYTIX PLC ADS RNLXY |
CVI Investments, Inc. | 8,547,788 6.900% |
8,547,788 (New Position) |
Filing History |
| 2024-02-16 11:28 am Purchase |
2024-02-08 | 13G | Tenax Therapeutics, Inc. TENX |
CVI Investments, Inc. | 204,027 9.900% |
204,027 (New Position) |
Filing History |
| 2024-02-14 2:14 pm Purchase |
2023-12-31 | 13G | Evofem Biosciences, Inc. EVFM |
CVI Investments, Inc. | 102,799 0.900% |
102,799 (New Position) |
Filing History |
| 2024-02-14 2:14 pm Unchanged |
2023-12-31 | 13G | Sidus Space, Inc. SIDU |
CVI Investments, Inc. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 2:14 pm Unchanged |
2023-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX |
CVI Investments, Inc. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 2:14 pm Sale |
2023-12-31 | 13G | Bitfarms Ltd. BITF |
CVI Investments, Inc. | 9,259,260 2.800% |
-9,259,260 (-50.00%) |
Filing History |
| 2024-02-14 2:14 pm Purchase |
2023-12-31 | 13G | Enservco Corporation ENSV |
CVI Investments, Inc. | 1,411,740 4.900% |
411,740 (+41.17%) |
Filing History |
| 2024-02-14 2:14 pm Sale |
2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
CVI Investments, Inc. | 0 0.000% |
-5,500,000 (Position Closed) |
Filing History |
| 2024-02-14 2:14 pm Unchanged |
2023-12-31 | 13G | DUET Acquisition Corp. DUET |
CVI Investments, Inc. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 2:14 pm Purchase |
2023-12-31 | 13G | Aditxt, Inc. ADTX |
CVI Investments, Inc. | 0 0.500% |
0 (New Position) |
Filing History |
| 2024-02-14 2:14 pm Purchase |
2023-12-31 | 13G | Ryvyl Inc. RVYL |
CVI Investments, Inc. | 596,135 9.900% |
596,135 (New Position) |
Filing History |
| 2024-02-14 2:14 pm Purchase |
2023-12-31 | 13G | Nova LifeStyle, Inc. NVFY |
CVI Investments, Inc. | 74,300 4.300% |
74,300 (New Position) |
Filing History |
| 2024-02-14 2:14 pm Purchase |
2023-12-31 | 13G | iCoreConnect Inc. ICCT |
CVI Investments, Inc. | 19,118 4.100% |
19,118 (New Position) |
Filing History |